NEW YORK (GenomeWeb) – Siemens Healthineers announced today that it has reached a deal to acquire Fast Track Diagnostics. The acquisition adds more than 80 platform-agnostic assays and syndromic panels to the menu of tests for Siemens' Versant kPCR Molecular System.

The acquisition also includes a workforce of about 80 employees and sites in FTD’s home base of Luxembourg, as well as in Malta and India. FTD will continue to operate under the brand name Fast Track Diagnostics throughout the world, Siemens said in a statement.

Terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Oct
02
Sponsored by
Roche

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.